c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma-Reference-Cited by-同舟云学术

c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma

Published:2014-03-27 Issue:5 Volume:59 Page:1850-1863
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wang Lei¹²,Zhang Xiang²,Jia Lin-Tao²,Hu Si-Jun³,Zhao Jing²,Yang Jian-Dong⁴,Wen Wei-Hong¹,Wang Zhe⁵,Wang Tao¹,Zhao Jun⁵,Wang Rui-An⁵,Meng Yan-Ling¹,Nie Yong-Zhan³,Dou Ke-Feng⁴,Chen Si-Yi⁶,Yao Li-Bo²,Fan Dai-Ming³,Zhang Rui²,Yang An-Gang¹²

Affiliation:

1. State Key Laboratory of Cancer Biology, Department of Immunology; Fourth Military Medical University; Xi'an China

2. Department of Biochemistry and Molecular Biology; Fourth Military Medical University; Xi'an China

3. Institute of Digestive Diseases, Xijing Hospital; Fourth Military Medical University; Xi'an China

4. Department of Hepatobiliary Surgery, Xijing Hospital; Fourth Military Medical University; Xi'an China

5. Department of Pathology; Fourth Military Medical University; Xi'an China

6. Department of Molecular Microbiology and Immunology, Norris Comprehensive Cancer Center, Keck School of Medicine; University of Southern California; Los Angeles CA

Publisher

Wiley

Subject

Hepatology

Reference45 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Molecular mechanism of liver cancer;Pan;Anticancer Agents Med Chem,2011

3. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009

4. microRNA involvement in hepatocellular carcinoma;Negrini;Anticancer Agents Med Chem,2011

5. MicroRNAs in cancer: small molecules with a huge impact;Iorio;J Clin Oncol,2009

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis;Frontiers in Genetics;2024-09-10

2. Revolutionizing HCV Therapy: microRNA Approaches in New Era of Treatment;Liver Cancer - Multidisciplinary Approach;2024-07-11

3. LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p;Journal of Cancer;2024

4. The tumor inhibitory function of growth differentiation factors on hepatocellular carcinoma;2023-11-29

5. MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?;Cancers;2023-11-23